Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

Sudan ,San Diego ,California ,United States ,New Jersey ,United Kingdom ,Wuhan ,Hubei ,China ,White House ,District Of Columbia ,American ,Christopherj Schaber ,Pontifax Medison ,Neal Bhatia ,Axel Lehrer ,Us Congress ,Emergent Manufacturing Operations Baltimore ,Linkedin ,Public Health Solutions Business Segment ,Twitter ,Emergent Product Development Gaithersburg ,National Institute Of Allergy ,Emergent Biosolutions Inc ,American Arbitration Association In Mercer ,Nasdaq ,Soligenix Inc ,Clinical Dermatology At Therapeutics Research ,Defense Threat Reduction Agency ,Phase Ii Small Business Innovation Research ,Us Development ,National Institutes Of Health ,Biomedical Advanced Research ,Prnewswire Soligenix Inc ,Drug Administration ,Development Authority ,Regulatory Agency ,Exchange Commission ,Public Health Solutions ,European Medicines Agency ,University Of Hawaii At Manoa ,Our Public Health Solutions ,Chief Executive Officer ,Marburg Viruses ,Coronavirus Disease ,Emergent Biosolutions ,Light Activated Synthetic ,Orphan Drug ,Fast Track ,Pediatric Investigation Plan ,Promising Innovative Medicine ,Innovative Licensing ,Access Pathway ,Clinical Dermatology ,Therapeutics Clinical Research ,Galera Therapeutics ,Priority Review Voucher ,Pandemic Preparedness ,Transforming Our ,Business Innovation Research ,National Institute ,Infectious Diseases ,National Institutes ,Ebola Virus Disease ,American Arbitration Association ,Mercer County ,Chief Executive ,Project Bioshield ,Soligenix ,Nc ,Biotechnology ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,